Volunteer Assignments and Opportunities
Revision as of 09:41, 28 October 2022 by Bailey.Glen (talk | contribs)
Welcome!
- For assignments, please see the "Author" column below. If no name is present, volunteer to create content!
- We will be creating content for all entities with genetic findings in the current WHO Classification of Tumours books. If there is an entity not yet listed below that you would like to author in any WHO book, we would be happy to create a page for you now.
- To volunteer, please Contact us with your page of interest.
- NOTE: A new version of the Heme/Lymphoid book (5th edition) is in beta form on the WHO website with publication of a final form anticipated by mid-2023; we're working on a plan to align the related CCGA content to the new structure.
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
|---|---|---|---|---|---|---|---|---|---|
| Myeloproliferative Neoplasms (MPN) | Overview | Mark Evans (trainee), Fabiola Quintero-Rivera | complete | Fabiola Quintero-Rivera (FQR) | Date page was created | ||||
| Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive | Disease | Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera | complete | FQR | Date page was created | ||||
| Chronic Neutrophilic Leukemia (CNL) | Disease | Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera | complete | FQR | Date page was created | ||||
| Polycythaemia Vera (PV) | Disease | Gokce A. Toruner | complete | FQR | |||||
| Primary Myelofibrosis (PMF) | Disease | T. Niroshi Senaratne | complete | FQR | 8/4/2020 before submission | ||||
| Essential Thrombocythaemia (ET) | Disease | Rebecca Smith | complete | FQR | 8/1/21 FQR deleted "This page is under construction | ||||
| Chronic Eosinophilic Leukemia, Not Otherwise Specified | Disease | Chelsea D. Kramish (trainee), Daynna J.Wolff | complete/pending faculty review | FQR | |||||
| Myeloproliferative Neoplasm (MPN), Unclassifiable | Disease | Thomas Lee | complete | FQR | |||||
| Mastocytosis | Overview | Shashi Shetty, Ph.D. | complete | FQR | |||||
| Cutaneous Mastocytosis | Disease | Thuy Phung + Shuo-Shawn Liu (trainee) | complete | FQR | 8/1/21 FQR deleted "This page is under construction | ||||
| Systemic Mastocytosis | Disease | Shashi Shetty | complete | FQR | |||||
| Mast Cell Sarcoma | Disease | Thuy Phung +Jordan Lowery (trainee) | complete | FQR | |||||
| Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 | Overview | Daynna J.Wolff | complete | FQR | |||||
| Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement | Disease | Jay Alden (trainee) +Daynna J.Wolff | Complete | FQR | |||||
| Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement | Disease | Christopher Sullivan (trainee) + Daynna J.Wolff | Complete | FQR | |||||
| Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement | Disease | Yanna Ding | Complete | FQR | |||||
| Myeloid/Lymphoid Neoplasms with PCM1-JAK2 | Disease | Jessica Snider (trainee) + Daynna J.Wolff | Complete | FQR | |||||
| Myeloid/Lymphoid Neoplasms with ETV6-JAK2 | Disease | Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff | Complete | FQR | NON-WHO ENTITY | ||||
| Myeloid/Lymphoid Neoplasms with BCR-JAK2 | Disease | Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff | Complete | FQR | NON-WHO ENTITY | ||||
| Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) | Overview | Linsheng Zhang | Complete | FQR | |||||
| Chronic Myelomonocytic Leukemia (CMML) | Disease | Linsheng Zhang | Complete | FQR | |||||
| Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative | Disease | Linsheng Zhang | Complete | FQR | |||||
| Juvenile Myelomonocytic Leukemia (JMML) | Disease | Sarah Rapisardo | 9/1/20 | PENDING importing content and reference formatting | FQR | FQR has emailed SR several times, last 4/20/22 | |||
| Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) | Disease | Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera | complete | FQR | Date page was created | ||||
| Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable | Disease | Ruth MacKinnon | complete | FQR | |||||
| Myelodysplastic Syndromes (MDS) | Overview | Jack Reid (trainee)+Fabiola Quintero-Rivera | 4/21/22 | pending | FQR | ||||
| Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia | Disease | Xiaoli Du(trainee) +Teresa Smolarek | 9/1/20 | PENDING | FQR | ||||
| Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS) | Disease | Xiaolin Hu(trainee)+Teresa Smolarek | Complete | FQR | |||||
| Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia | Disease | Xiaolin Hu(trainee)+Teresa Smolarek | Complete | FQR | |||||
| Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia | Disease | Xiaoli Du(trainee)+Teresa Smolarek | Complete | FQR | |||||
| Myelodysplastic Syndrome (MDS) with Excess Blasts | Disease | Xiaoli Du(trainee)+Teresa Smolarek | 9/1/20 | Complete | FQR | ||||
| Myelodysplastic Syndrome (MDS) with Isolated del(5q) | Disease | Xiaolin Hu(trainee)+Teresa Smolarek | Complete | FQR | |||||
| Myelodysplastic Syndrome (MDS), Unclassifiable | Disease | Xiaolin Hu(trainee)+Teresa Smolarek | complete | FQR | |||||
| Refractory Cytopenia of Childhood | Disease | Xiaoli Du(trainee)+Teresa Smolarek | 9/1/20 | Complete | FQR | ||||
| Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms | Overview | Daynna Wolff+Daniel Butler (Path Resident) | Complete | Jennelle Hodge (JH)/ Malini Sathanoori (MS) | 04/26/2021 -MS (re-review) | ||||
| Myeloid Neoplasms with Germline Predisposition | Overview | Ying Zou | Complete | JH / MS | 03/01/2021-MS (re-review) | ||||
| Acute Myeloid Leukaemia with Germline CEBPA Mutation | Disease | Daynna Wolff+Matthew Kilpatrick (Path Resident) | JH / MS | 04/26/2021 -MS (re-review) | Review completed, awaiting some clarification from JH - 07/04/2022 | ||||
| Myeloid Neoplasms with Germline DDX41 Mutation | Disease | Fei Yang | Complete | JH / MS | 03/01/2021-MS | ||||
| Myeloid Neoplasms with Germline RUNX1 Mutation | Disease | Malini Sathanoori | Complete | 02/03/2021 | JH / MS | ||||
| Myeloid Neoplasms with Germline ANKRD26 Mutation | Disease | Fei Yang | Complete | JH / MS | 03/02/2021-MS | ||||
| Myeloid Neoplasms with Germline ETV6 Mutation | Disease | Ying Zou | Complete | JH / MS | 03/02/2021-MS (re-review) | ||||
| Myeloid Neoplasms with Germline GATA2 Mutation | Disease | Daynna Wolff+ Alexandria Avery (Path Resident) | Complete | JH / MS | 04/26/2021 -MS (re-review) | ||||
| Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities | Overview | Daynna Wolff+ Dan Wang (trainee) | Complete | JH / MS | 03/01/2021-MS (re-review) | ||||
| Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 | Disease | Christine Bryke | Complete | JH / MS | 04/26/2021-MS (re-review) | ||||
| Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | Disease | Christine Bryke | Complete | JH / MS | 03/01/2021-MS (re-review) | ||||
| Acute Promyelocytic Leukemia (APL) with PML-RARA | Disease | Shashi Shetty | Complete | JH / MS | 03/01/2021-MS (re-review) | ||||
| Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 | Disease | Shashi Shetty | Complete | JH / MS | 03/01/2021-MS (re-review) | ||||
| Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 | Disease | Jennelle Hodge | Complete | JH / MS | 02/24/2021-MS (re-review) | ||||
| Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM | Disease | Gordana Raca | Complete | JH / MS | Need permission for figure? Update WHO? | ||||
| Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 | Disease | Jennelle Hodge | Complete | JH / MS | |||||
| Acute Myeloid Leukemia (AML) with BCR-ABL1 | Disease | Kay Weng Choy + Greg
Corboy (Monash Health) |
Complete | JH / MS | |||||
| Acute Myeloid Leukemia (AML) with Mutated NPM1 | Disease | Xinjie Xu | Complete | JH / MS | Add WHO reference | ||||
| Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA | Disease | Paul deFazio, MSc + Greg Corboy (Monash Health) | Complete | JH / MS | |||||
| Acute Myeloid Leukemia (AML) with Mutated RUNX1 | Disease | Daynna Wolff+Iris Martin (Path Resident) | Complete | JH / MS | |||||
| Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes | Disease | Fei Yang | Complete | JH / MS | |||||
| Therapy-Related Myeloid Neoplasms | Disease | Shashi Shetty + Shawn A. Silver (resident) | Complete | JH / MS | Check reference format | ||||
| Acute Myeloid Leukemia (AML), Not Otherwise Specified | Overview | Anwar Iqbal | Complete | JH / MS | |||||
| Acute Myeloid Leukemia (AML) with Minimal Differentiation | Disease | Fabiola Quintero-Rivera and Celeste Eno (fellow) | Complete | JH / MS | |||||
| Acute Myeloid Leukemia (AML) without Maturation | Disease | Jennelle Hodge | Complete | JH / MS | |||||
| Acute Myeloid Leukemia (AML) with Maturation | Disease | Jennelle Hodge | Complete | JH / MS | |||||
| Acute Myelomonocytic Leukemia | Disease | Fei Yang | Complete | JH / MS | |||||
| Acute Monoblastic and Monocytic Leukemia | Disease | Fei Yang | Complete | JH / MS | |||||
| Pure Erythroid Leukemia | Disease | Ash Yenamandra | Complete | JH / MS | |||||
| Acute Megakaryoblastic Leukemia (AMKL) | Disease | Fei Yang | Complete | JH / MS | |||||
| Acute Basophilic Leukemia | Disease | Ash Yenamandra | Complete | JH / MS | |||||
| Acute Panmyelosis with Myelofibrosis | Disease | Ying Zou and Jialing Huang (MGP fellow) | Complete | JH / MS | |||||
| Myeloid Sarcoma | Disease | Fabiola Quintero-Rivera | Complete | JH / MS | |||||
| Myeloid Proliferations Associated with Down Syndrome | Overview | Patty Greipp | Complete | JH / MS | Need permission for figure? | ||||
| Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome | Disease | Linda Cooley | Complete | JH / MS | |||||
| Myeloid Leukemia Associated with Down Syndrome | Disease | Linda Cooley | Complete | JH / MS | |||||
| Blastic Plasmacytoid Dendritic Cell Neoplasm | Disease | Daynna Wolff+Hao Liu (Path Resident) | Complete | JH / MS | |||||
| Acute Leukemias of Ambiguous Lineage | Overview | Hui Chen/ Jennelle Hodge | Complete | JH / MS | |||||
| Acute Undifferentiated Leukemia | Disease | Shashi Shetty + Amelia Nakanishi (resident) | Complete | JH / MS | Check reference format | ||||
| Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 | Disease | Tracy Tucker | Complete | JH / MS | |||||
| Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged | Disease | Tracy Tucker | Complete | JH / MS | |||||
| Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified | Disease | Shashi Shetty + Priyatharsini Nirmalanantham (resident) | Complete | JH / MS | |||||
| Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified | Disease | Fabiola Quintero-Rivera | Complete | JH / MS | |||||
| Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types | Disease | Daynna Wolff+ Elicia Goodale (resident) | PENDING | JH / MS | |||||
| Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS) | Disease | Daynna Wolff+Madison Hannay or Elicia Goodale (residents) | PENDING | JH / MS | |||||
| Acute Myeloid Leukemia (AML) with Mutated FLT3 | Disease | Kay Weng Choy + Greg Corboy (Monash Health) | Complete | JH / MS | NON-WHO ENTITY | ||||
| Acute Myeloid Leukemia (AML) with NUP214-ABL1 | Disease | Daynna Wolff+Jessica Snider (Path Resident) | PENDING | JH / MS | NON-WHO ENTITY | ||||
| Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 | Disease | Daynna Wolff+ Paige Woodham (Path Resident) | PENDING | JH / MS | NON-WHO ENTITY | ||||
| Precursor Lymphoid Neoplasms | Overview | Yassmine Akkari (YA) | |||||||
| B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities | Overview | YA | |||||||
| B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 | Disease | Afia Hasnain (trainee) + Yassmine Akkari | PENDING | YA | |||||
| B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged | Disease | Yassmine Akkari+Nicolas Millan (trainee) | PENDING | YA | |||||
| B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 | Disease | Marilena Melas + Yassmine Akkari | PENDING | YA | |||||
| B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy | Disease | Afia Hasnain + Yassmine Akkari | PENDING | YA | |||||
| B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy | Disease | Ashwini Yenamandra +
Lisa Smith + Yassmine Akkari |
Complete | YA | |||||
| B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3 | Disease | Binu Porath + Linda Cooley | PENDING | YA | |||||
| B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 | Disease | Binu Porath + Linda Cooley | PENDING | YA | |||||
| B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like | Disease | Mark G. Evans + Fabiola Quintero-Rivera | Complete | YA | |||||
| B-Lymphoblastic Leukemia/Lymphoma with iAMP21 | Disease | Holli Drendel | Complete | YA | |||||
| B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified | Disease | Holli Drendel | PENDING | YA | |||||
| B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 | Disease | Diana Rush | PENDING | YA | NON-WHO ENTITY | ||||
| B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 | Disease | Celeste Eno | PENDING | YA | NON-WHO ENTITY | ||||
| B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements | Disease | Marilena Melas | PENDING | YA | NON-WHO ENTITY | ||||
| B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions | Disease | Chenkai Ma | PENDING | YA | NON-WHO ENTITY | ||||
| B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19) | Disease | Celeste Eno | PENDING | YA | NON-WHO ENTITY | ||||
| B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11) | Disease | Alaa Koleilat | PENDING | YA | NON-WHO ENTITY | ||||
| T-Lymphoblastic Leukemia/Lymphoma | Overview | Fei Yang | PENDING | YA | |||||
| Early T-Cell Precursor Lymphoblastic Leukemia | Disease | Fei Yang | PENDING | YA | 2021 template added | ||||
| NK-Lymphoblastic Leukemia/Lymphoma | Disease | Fei Yang | PENDING | YA | 2021 template added | ||||
| Mature B-Cell Neoplasms | Overview | Snehal Patel (SP) | |||||||
| Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Disease | SP | |||||||
| Monoclonal B-cell Lymphocytosis | Disease | SP | 2021 template added | ||||||
| B-cell Prolymphocytic Leukemia | Disease | Zejuan Li | 4/28/22 | PENDING | SP | 2021 template added | |||
| Splenic Marginal Zone Lymphoma | Disease | Snehal Patel | Complete | SP | |||||
| Hairy Cell Leukemia | Disease | Snehal Patel | Complete | SP | |||||
| Splenic B-cell Lymphoma/Leukemia, Unclassifiable | Overview | Snehal Patel | Complete | SP | |||||
| Splenic Diffuse Red Pulp Small B-cell Lymphoma | Disease | Snehal Patel | Complete | SP | |||||
| Hairy Cell Leukemia Variant | Disease | Snehal Patel | Complete | SP | |||||
| Lymphoplasmacytic Lymphoma | Disease | Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera | PENDING review by FQR | SP | 2021 template added | ||||
| Waldenstrom Macroglobulinemia | Disease | Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera | PENDING review by FQR | SP | 2021 template added | ||||
| IgM Monoclonal Gammopathy of Undetermined Significance | Disease | SP | |||||||
| Heavy Chain Diseases | Overview | SP | |||||||
| Mu Heavy Chain Disease | Disease | SP | |||||||
| Gamma Heavy Chain Disease | Disease | Manisha Sutariya | Complete | 5/26/2021 | SP | ||||
| Alpha Heavy Chain Disease | Disease | SP | |||||||
| Plasma Cell Neoplasms | Overview | Zhenya Tang | PENDING | SP | |||||
| Non-IgM Monoclonal Gammopathy of Undetermined Significance | Disease | Zhenya Tang | PENDING | SP | |||||
| Plasma Cell Myeloma | Disease | Zhenya Tang/Huang Mo (trainee) | PENDING | SP | |||||
| Plasma Cell Myeloma Variants | Disease | Fariborz Rashid-Kolvear | PENDING | SP | |||||
| Plasmacytoma | Disease | Zhenya Tang | PENDING | SP | |||||
| Monoclonal Immunoglobulin Deposition Diseases | Overview | Chen Yang, MD, PhD | Complete | 09/10/2022 | SP | ||||
| Primary Amyloidosis | Disease | Heather E. Williams, PhD | ?PENDING | SP | |||||
| Light Chain and Heavy Chain Deposition Disease | Disease | Chen Yang, MD, PhD | Complete | 10/15/2022 | SP | ||||
| Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome | Overview | Sohini Anand | 8/31/2021 | 9/15/2021 | PENDING | SP | |||
| POEMS Syndrome | Disease | Sohini Anand, MBBS, and Tharanga Niroshini Senaratne, PhD | ?PENDING | SP | |||||
| TEMPI Syndrome | Disease | Sohini Anand, MBBS | ?PENDING | SP | |||||
| Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) | Disease | Whayoung Lee (trainee)/Fabiola Quintero-Rivera | 3/9/21 | PENDING | SP | 2021 template added | |||
| Nodal Marginal Zone Lymphoma | Disease | Shivani Golem | Complete | 5/28/2021 | SP | ||||
| Paediatric Nodal Marginal Zone Lymphoma | Disease | Ruthann Pfau, Kathleen Schieffer (trainee) | Complete | 11/11/2020 | SP | ||||
| Follicular Lymphoma | Disease | Ruthann Pfau | PENDING | SP | |||||
| Testicular Follicular Lymphoma | Disease | Ruthann Pfau | PENDING | SP | |||||
| In Situ Follicular Neoplasia | Disease | Ruthann Pfau | PENDING | SP | |||||
| Duodenal-Type Follicular Lymphoma | Disease | Ruthann Pfau | PENDING | SP | |||||
| Paediatric-Type Follicular Lymphoma | Disease | Ruthann Pfau, Kathleen Schieffer (trainee) | Complete | 8/16/2020 | SP | ||||
| Large B-cell Lymphoma with IRF4 Rearrangement | Disease | Afia Hasnaid | 9/30/20 | Complete | 5/26/2021 | SP | |||
| Primary Cutaneous Follicle Centre Lymphoma | Disease | Shivani Golem | Complete | 09/10/2022 | SP | ||||
| Mantle Cell Lymphoma | Disease | Mahsa Khanlari | 8/15/20 | PENDING | SP | ||||
| Leukemic Non-Nodal Mantle Cell Lymphoma | Disease | Mahsa Khanlari, MD | ?PENDING | SP | |||||
| In Situ Mantle Cell Neoplasia | Disease | Rina Kansal, MD | 6/12/22 | Complete | 7/26/2022 | SP | 2021 template added | ||
| Diffuse Large B-cell Lymphoma, Not Otherwise Specified | Disease | Ashwini Yenamandra | PENDING | Greg Corboy (GC) | Requested to update 14022022 | ||||
| T-cell/Histiocyte-Rich Large B-cell Lymphoma | Disease | GC | |||||||
| Primary Diffuse Large B-cell Lymphoma of the CNS | Disease | Laveniya Satgunaseelan | 26/10/2021 | 26/1/2022 | Complete | 03/28/22 | GC | 03/28/22 | 2021 template added |
| Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type | Disease | GC | |||||||
| EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) | Disease | GC | |||||||
| EBV-Positive Mucocutaneous Ulcer | Disease | GC | |||||||
| Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation | Disease | GC | |||||||
| Fibrin-Associated Diffuse Large B-cell Lymphoma | Disease | GC | |||||||
| Lymphomatoid Granulomatosis | Disease | GC | |||||||
| Primary Mediastinal (Thymic) Large B-cell Lymphoma | Disease | GC | |||||||
| Intravascular Large B-cell Lymphoma | Disease | Kate Berry, Greg Corboy | 25/01/2022 | 25/4/2022 | Complete | 9/1/22 | GC | 9/1/22 | Emailed 28/3/2022 for progress update |
| ALK-Positive Large B-cell Lymphoma | Disease | Nakasaki Manando | PENDING | GC | Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note). 2021 template added. | ||||
| Plasmablastic Lymphoma | Disease | Mark Evans (trainee), Fabiola Quintero-Rivera | Complete | GC | 28/03/2022 | ||||
| Primary Effusion Lymphoma | Disease | GC | |||||||
| HHV8-Associated Lymphoproliferative Disorders | Overview | GC | |||||||
| Multicentric Castleman Disease | Disease | Sudha Arumugam | 10/26/2021 | 1/26/2022 | Complete | 24/01/2022 | GC | 24/01/2022 | 2021 template added |
| HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) | Disease | Xiao Zhou, MD, PhD, Siparadigm | 10/26/2021 | 1/26/2022 | PENDING | GC | Emailed 28/3/2022 for progress update | ||
| HHV8-Positive Germinotropic Lymphoproliferative Disorder | Disease | Xiao Zhou, MD, PhD, Siparadigm | 10/26/2021 | 1/26/2022 | PENDING | GC | Emailed 28/3/2022 for progress update | ||
| Burkitt Lymphoma | Disease | Becky Leung (trainee), Greg Corboy | 3/11/21 | 06/28/2021 | Complete | 28/06/2021 | GC | 28/06/2021 | |
| Burkitt-Like Lymphoma with 11q Aberration | Disease | Lauren Shealy (trainee), Daynna Wolff | 10/13/21 | 01/13/2022 | Complete | 27/01/2022 | GC | 27/01/2021 | 2021 template added |
| High-Grade B-cell Lymphoma | Overview | GC | |||||||
| High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements | Disease | Kate Berry, Greg Corboy | 30/05/21 | 30/08/21 | Complete | 24/02/2022 | GC | 24/02/2022 | |
| High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS) | Disease | Aiko Otsubo, Holli Drendel | 7/30/21 | 10/30/21 | Complete | 15/11/2021 | GC | 16/11/2021 | |
| B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma | Disease | GC | |||||||
| Mature T- and NK-cell Neoplasms | Overview | Snehal Patel (SP) | |||||||
| T-cell Prolymphocytic Leukemia | Disease | Michelle Don | PENDING | SP | |||||
| T-cell Large Granular Lymphocytic Leukemia | Disease | Michelle Don | PENDING | SP | |||||
| Chronic Lymphoproliferative Disorder of NK Cells | Disease | Michelle Don | PENDING | SP | |||||
| Aggressive NK-cell Leukemia | Disease | Shanelle De Lancy, MD, Shashirekha Shetty, PhD | ?PENDING | SP | |||||
| EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood | Overview | SP | |||||||
| Systemic EBV-Positive T-cell Lymphoma of Childhood | Disease | Lisa Lansdon (trainee) | Complete | 11/21/2021 | SP | ||||
| Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form | Disease | SP | |||||||
| Hydroa Vacciniforme-Like Lymphoproliferative Disorder | Disease | SP | |||||||
| Severe Mosquito Bite Allergy | Disease | SP | |||||||
| Adult T-cell Leukemia/Lymphoma | Disease | Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG | ?PENDING | SP | |||||
| Extranodal NK/T-cell Lymphoma, Nasal Type | Disease | SP | |||||||
| Intestinal T-cell Lymphoma | Overview | Sumire Kitahara, Derick Okwan (trainee) | Complete | 9/26/2022 | SP | ||||
| Enteropathy-Associated T-cell Lymphoma | Disease | Sumire Kitahara, Derick Okwan (trainee) | Complete | 1/21/2021 | SP | ||||
| Monomorphic Epitheliotropic Intestinal T-cell Lymphoma | Disease | Sumire Kitahara | PENDING | SP | |||||
| Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS) | Disease | Sumire Kitahara, Derick Okwan (trainee) | Complete | 9/26/2022 | SP | ||||
| Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract | Disease | Sumire Kitahara, Derick Okwan (trainee) | PENDING | SP | |||||
| Hepatosplenic T-cell Lymphoma | Disease | Michelle Don | Complete | 1/21/2021 | SP | ||||
| Subcutaneous Panniculitis-Like T-cell Lymphoma | Disease | SP | |||||||
| Mycosis Fungoides | Disease | Daynna Wolff, Jane Scribner (trainee) | PENDING | SP | |||||
| Sézary Syndrome | Disease | Daynna Wolff, Madison Hannay (trainee), Tingting Barrett (trainee) | PENDING | SP | |||||
| Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders | Overview | Peining Li, PhD | PENDING | SP | |||||
| Lymphomatoid Papulosis | Disease | Peining Li, PhD | PENDING | SP | |||||
| Primary Cutaneous Anaplastic Large Cell Lymphoma | Disease | Theresa Spivey, MD, Shashirekha Shetty, PhD | PENDING | SP | |||||
| Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes | Overview | Peining Li, PhD | PENDING | SP | |||||
| Primary Cutaneous Gamma Delta T-cell Lymphoma | Disease | Peining Li, PhD | PENDING | SP | |||||
| Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma | Disease | Peining Li, PhD | PENDING | SP | |||||
| Primary Cutaneous Acral CD8+ T-cell Lymphoma | Disease | Peining Li, PhD | PENDING | SP | |||||
| Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder | Disease | Peining Li, PhD | PENDING | SP | |||||
| Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS) | Disease | SP | |||||||
| Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin | Overview | SP | |||||||
| Angioimmunoblastic T-cell Lymphoma | Disease | Ruthann Pfau, Sara Akhavanfard (trainee) | PENDING | SP | |||||
| Follicular T-cell Lymphoma | Disease | Ruthann Pfau, Sara Akhavanfard (trainee) | PENDING | SP | |||||
| Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype | Disease | Hans Hamnvåg | PENDING | SP | |||||
| Anaplastic Large Cell Lymphoma, ALK-Positive | Disease | Sumire Kitahara / Miguel Gonzalez (trainee) | Completed | 09/23/2022 | SP | ||||
| Anaplastic Large Cell Lymphoma, ALK-Negative | Disease | Sumire Kitahara / Miguel Gonzalez (trainee) | Completed | 09/23/2022 | SP | ||||
| Breast Implant-Associated Anaplastic Large Cell Lymphoma | Disease | Sumire Kitahara | PENDING | SP | |||||
| Hodgkin Lymphomas | Overview | Greg Corboy (GC) | |||||||
| Nodular Lymphocyte Predominant Hodgkin Lymphoma | Disease | Thomas Harrington (resident) + Daynna Wolff | 06/22/2022 | 09/22/2022 | PENDING | GC | 2021 template added, Daynna organising | ||
| Classic Hodgkin Lymphoma | Overview | GC | |||||||
| Nodular Sclerosis Classic Hodgkin Lymphoma | Disease | Xiaolin (Lynn) Hu | Completed | 03/21/22 | GC | 03/21/22 | Edits sent 14022022 | ||
| Lymphocyte-Rich Classic Hodgkin Lymphoma | Disease | Patricia V. Hernandez, M.D. (trainee)+Holli Drendel | PENDING | GC | 2021 template added | ||||
| Mixed Cellularity Classic Hodgkin Lymphoma | Disease | Patricia V. Hernandez, M.D. (trainee)+Holli Drendel | PENDING | GC | 2021 template added | ||||
| Lymphocyte-Depleted Classic Hodgkin Lymphoma | Disease | Patricia V. Hernandez, M.D. (trainee)+Holli Drendel | PENDING | GC | 2021 template added | ||||
| Immunodeficiency-Associated Lymphoproliferative Disorders | Overview | GC | |||||||
| Lymphomas Associated with HIV Infection | Disease | Patricia V. Hernandez, M.D. (trainee)+Holli Drendel | 11/2/21 | 02/02/22 | Completed | 03/21/22 | GC | 03/21/22 | 2021 template added |
| Post-Transplant Lymphoproliferative Disorders | Overview | GC | |||||||
| Non-Destructive Post-Transplant Lymphoproliferative Disorders | Disease | GC | |||||||
| Polymorphic Post-Transplant Lymphoproliferative Disorders | Disease | Ania Shestakova (trainee) + Fabiola Quintero-Rivera | completed | april 2022 | GC | 26/4/2022 | |||
| Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types) | Overview | GC | |||||||
| Monomorphic B-cell PTLD | Disease | GC | |||||||
| Monomorphic T/NK-cell PTLD | Disease | GC | |||||||
| Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder | Disease | GC | |||||||
| Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders | Disease | GC | |||||||
| Histiocytic and Dendritic Cell Neoplasms | Overview | GC | |||||||
| Histiocytic Sarcoma | Disease | Marie-France Gagnon, MD, Mayo Clinic (LGG fellow trainee), Xinjie Xu, PhD FACMG, Mayo Clinic | Complete | 10/01/2021 | GC | 10/01/2021 | Xinjie Xu | ||
| Tumors Derived From Langerhans Cells | Overview | GC | |||||||
| Langerhans Cell Histiocytosis | Disease | Malaika Perchard, Greg Corboy | 02/01/2022 | 05/01/2022 | Complete | 04/28/2022 | GC | 5/19/2022 | |
| Langerhans Cell Sarcoma | Disease | Malaika Perchard, Greg Corboy | 02/01/2022 | 05/01/2022 | Complete | 04/28/2022 | GC | 5/19/2022 | |
| Indeterminate Dendritic Cell Tumour | Disease | GC | |||||||
| Interdigitating Dendritic Cell Sarcoma | Disease | GC | |||||||
| Follicular Dendritic Cell Sarcoma | Disease | GC | |||||||
| Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma | Disease | GC | |||||||
| Fibroblastic Reticular Cell Tumor | Disease | GC | |||||||
| Disseminated Juvenile Xanthogranuloma | Disease | GC | |||||||
| Erdheim-Chester Disease | Disease | Prashant Deshpande | 02/02/2022 | 05/02/2022 | PENDING | GC | emailed 28/3/2022 to get update | ||
WHO Classification of Tumours of the Central Nervous System Content
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
|---|---|---|---|---|---|---|---|---|---|
| Medulloblastoma, WNT-activated | Disease | Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City | 9/20/21 | COMPLETE | Holli Drendel (interim)/Laveniya Satgunaseelan (LS) | 9/22/2022 | 2021 template added | ||
| Paediatric-Type Diffuse High-Grade Gliomas | Overview | 2021 template added | |||||||
| Diffuse Midline Glioma, H3 K27-Altered | Disease | Laveniya Satgunaseelan (Linda Cooley - previous version) | PENDING | Laveniya Satgunaseelan (LS) | 2021 template added | ||||
| Diffuse Hemispheric Glioma, H3 G34-Mutant | Disease | Xiaolin (Lynn) Hu | 2/21/2022 | PENDING | LS | 2021 template added | |||
| Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype | Disease | 2021 template added | |||||||
| Infant-Type Hemispheric Glioma | Disease | 2021 template added | |||||||
| Astrocytoma, IDH-Mutant | Disease | Riley Lochner (trainee), Shashi Shetty (mentor) | 3/3/2022 | PENDING | LS | 2021 template added | |||
| Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted | Disease | Riley Lochner (trainee), Shashi Shetty (mentor) | 3/3/2022 | PENDING | LS | 2021 template added | |||
| Ganglioglioma | Disease | Leila Moayed-Aloei | 6/30/2022 | PENDING | LS | 2021 template added | |||
| Pilocytic Astrocytoma | Disease | Jeremy Pulvers | 9/13/2022 | PENDING | LS | 2021 template added |
WHO Classification of Soft Tissue and Bone Tumours Content
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
|---|---|---|---|---|---|---|---|---|---|
| NTRK-Rearranged Spindle Cell Neoplasm | Disease | James Solomon, MD, PhD | 2/20/2022 | PENDING | Alanna Church |
WHO Classification of Tumours of Breast Tumours Content
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
|---|---|---|---|---|---|---|---|---|---|
| Adenoid Cystic Carcinoma | Disease | Katherine Geiersbach | 10/12/02022 | PENDING | Hui Chen | 2021 template added | |||
| Secretory Carcinoma | Disease | Hui Chen | 10/12/2022 | PENDING | Katherine Geiersbach | 2021 template added |
Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)
| Gene | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
|---|---|---|---|---|---|---|---|---|
| BCR | Brian Davis | Complete | 8/10/18 | |||||
| ABL1 | Brian Davis | Complete | 4/16/19 | |||||
| RUNX1 | Brian Davis | Complete | 6/9/19 | |||||
| RUNX1T1 | Brian Davis | Complete | 5/23/19 | |||||
| MYH11 | Brian Davis | Complete | 8/6/18 | |||||
| FLT3 | Kay Weng Choy | Complete | ||||||
| NPM1 | Kay Weng Choy | Complete | ||||||
| TP53 | Kay Weng Choy | Complete | ||||||
| DNMT3A | Kay Weng Choy | Complete | ||||||
| CEBPA | Gordana | Complete | ||||||
| IDH1 | Paul De Fazio | Complete | ||||||
| IDH2 | Paul De Fazio | Complete | ||||||
| PML | Brian Davis | Complete | 12/5/18 | |||||
| RARA | Brian Davis | Complete | 8/3/18 | |||||
| ETV6 | Brian Davis | Complete | 6/9/19 | |||||
| KIT | Brian Davis | Complete | 10/1/18 | |||||
| CBFB | Brian Davis | Complete | 8/2/18 | |||||
| GATA2 | Kay Weng Choy | Complete | ||||||
| PTEN | Beth Pitel | Pending | ||||||
| MLTT3 | ||||||||
| MECOM | Brian Davis | Pending | ||||||
| FGFR1(FLT2) | Brian Davis | Pending | ||||||
| KMT2A | ||||||||
| DEK | Wahab A. Khan | Pending | ||||||
| NUP214 | Wahab A. Khan | Pending | ||||||
| RBM15 | ||||||||
| MKL1 | ||||||||
| DDX41 | Ying Zou | 8/7/20 | Pending | |||||
| ANKRD26 | ||||||||
| CUX1 | ||||||||
| TET2 | ||||||||
| EZH2 | ||||||||
| FOXP1 | ||||||||
| MYC | ||||||||
| JAK2 | ||||||||
| WT1 | DONE | DONE | ||||||
| CBL | ||||||||
| NF1 | ||||||||
| SUZ12 | ||||||||
| ERG | ||||||||
| EST2 | ||||||||
| RPS14 | ||||||||
| RB1 | ||||||||
| MPL | ||||||||
| CHGA | ||||||||
| CDH1 | ||||||||
| SRSF2 | ||||||||
| DNMT1 | ||||||||
| PRDX2 | ||||||||
| ASXL1 | DONE | DONE | ||||||
| MN1 | ||||||||
| SF3A1 | ||||||||
| EP300 | ||||||||
| JARID2 | ||||||||
| BRCA1 | ||||||||
| BRCA2 | ||||||||
WHO Central Nervous System Tumours (5th ed.) Content
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
|---|---|---|---|---|---|---|---|---|---|
| Oligodendroglioma, IDH-mutant and 1p/19q-codeleted | Disease | ||||||||
| Glioblastoma, IDH-wildtype | Disease | ||||||||
| Diffuse astrocytoma, MYB- or MYBL1-altered | Disease | ||||||||
| Angiocentric glioma | Disease | ||||||||
| Polymorphous low-grade neuroepithelial tumour of the young | Disease | ||||||||
| Diffuse low-grade glioma, MAPK pathway-altered | Disease | ||||||||
| Diffuse midline glioma, H3 K27-altered | Disease | ||||||||
| Diffuse hemispheric glioma, H3 G34-mutant | Disease | ||||||||
| Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype | Disease | ||||||||
| Infant-type hemispheric glioma | Disease | ||||||||
| Pilocytic astrocytoma | Disease | ||||||||
| High-grade astrocytoma with piloid features | Disease | ||||||||
| Pleomorphic xanthoastrocytoma | Disease | ||||||||
| Subependymal giant cell astrocytoma | Disease | ||||||||
| Chordoid glioma | Disease | ||||||||
| Astroblastoma, MN1-altered | Disease | ||||||||
| Ganglioglioma | Disease | ||||||||
| Gangliocytoma | Disease | ||||||||
| Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma | Disease | ||||||||
| Dysembryoplastic neuroepithelial tumour | Disease | ||||||||
| Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters | Disease | ||||||||
| Papillary glioneuronal tumour | Disease | ||||||||
| Rosette-forming glioneuronal tumour | Disease | ||||||||
| Myxoid glioneuronal tumour | Disease | ||||||||
| Diffuse leptomeningeal glioneuronal tumour | Disease | ||||||||
| Multinodular and vacuolating neuronal tumour | Disease | ||||||||
| Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) | Disease | ||||||||
| Central neurocytoma | Disease | ||||||||
| Extraventricular neurocytoma | Disease | ||||||||
| Cerebellar liponeurocytoma | Disease | ||||||||
| Supratentorial ependymoma | Disease | ||||||||
| Supratentorial ependymoma, ZFTA fusion-positive | Disease | ||||||||
| Supratentorial ependymoma, YAP1 fusion-positive | Disease | ||||||||
| Posterior fossa ependymoma | Disease | ||||||||
| Posterior fossa group A (PFA) ependymoma | Disease | ||||||||
| Posterior fossa group B (PFB) ependymoma | Disease | ||||||||
| Spinal ependymoma | Disease | ||||||||
| Spinal ependymoma, MYCN-amplified | Disease | ||||||||
| Myxopapillary ependymoma | Disease | ||||||||
| Subependymoma | Disease | ||||||||
| Choroid plexus papilloma | Disease | ||||||||
| Atypical choroid plexus papilloma | Disease | ||||||||
| Choroid plexus carcinoma | Disease | ||||||||
| Medulloblastoma, WNT-activated | Disease | ||||||||
| Medulloblastoma, SHH-activated and TP53-wildtype | Disease | ||||||||
| Medulloblastoma, SHH-activated and TP53-mutant | Disease | ||||||||
| Medulloblastoma, non-WNT/non-SHH | Disease | ||||||||
| Medulloblastoma, histologically defined | Disease | ||||||||
| Atypical teratoid/rhabdoid tumour | Disease | ||||||||
| Cribriform neuroepithelial tumour | Disease | ||||||||
| Embryonal tumour with multilayered rosettes | Disease | ||||||||
| CNS neuroblastoma, FOXR2-activated | Disease | ||||||||
| CNS tumour with BCOR internal tandem duplication | Disease | ||||||||
| CNS embryonal tumour NEC/NOS | Disease | ||||||||
| Pineocytoma | Disease | ||||||||
| Pineal parenchymal tumour of intermediate differentiation | Disease | ||||||||
| Pineoblastoma | Disease | ||||||||
| Papillary tumour of the pineal region | Disease | ||||||||
| Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant | Disease | ||||||||
| Schwannoma | Disease | ||||||||
| Neurofibroma | Disease | ||||||||
| Perineurioma | Disease | ||||||||
| Hybrid nerve sheath tumours | Disease | ||||||||
| Malignant melanotic nerve sheath tumour | Disease | ||||||||
| Malignant peripheral nerve sheath tumour | Disease | ||||||||
| Cauda equina neuroendocrine tumour (previously paraganglioma) | Disease | ||||||||
| Meningioma | Disease | ||||||||
| Solitary fibrous tumour | Disease | ||||||||
| Haemangiomas and vascular malformations | Disease | ||||||||
| Haemangioblastoma | Disease | ||||||||
| Rhabdomyosarcoma | Disease | ||||||||
| Intracranial mesenchymal tumour, FET::CREB fusion-positive | Disease | ||||||||
| CIC-rearranged sarcoma | Disease | ||||||||
| Primary intracranial sarcoma, DICER1-mutant | Disease | ||||||||
| Ewing sarcoma | Disease | ||||||||
| Mesenchymal chondrosarcoma | Disease | ||||||||
| Chondrosarcoma | Disease | ||||||||
| Chordoma | Disease | ||||||||
| Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis | Disease | ||||||||
| Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma | Disease | ||||||||
| Primary diffuse large B-cell lymphoma of the CNS | Disease | ||||||||
| Immunodeficiency-associated CNS lymphomas | Disease | ||||||||
| Lymphomatoid granulomatosis | Disease | ||||||||
| Intravascular large B-cell lymphoma | Disease | ||||||||
| MALT lymphoma of the dura | Disease | ||||||||
| Other low-grade B-cell lymphomas of the CNS | Disease | ||||||||
| Anaplastic large cell lymphoma (ALK+/ALK−) | Disease | ||||||||
| T-cell and NK/T-cell lymphomas | Disease | ||||||||
| Erdheim-Chester disease | Disease | ||||||||
| Rosai-Dorfman disease | Disease | ||||||||
| Juvenile xanthogranuloma | Disease | ||||||||
| Langerhans cell histiocytosis | Disease | ||||||||
| Histiocytic sarcoma | Disease | ||||||||
| Germ cell tumours of the CNS | Disease | ||||||||
| Adamantinomatous craniopharyngioma | Disease | ||||||||
| Papillary craniopharyngioma | Disease | ||||||||
| Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma | Disease | ||||||||
| Pituitary adenoma / pituitary neuroendocrine tumour | Disease | ||||||||
| Pituitary blastoma | Disease | ||||||||
| Metastases to the brain and spinal cord parenchyma | Disease | ||||||||
| Metastases to the meninges | Disease | ||||||||
| Neurofibromatosis type 1 | Disease | ||||||||
| Neurofibromatosis type 2 | Disease | ||||||||
| Schwannomatosis | Disease | ||||||||
| Von Hippel-Lindau syndrome | Disease | ||||||||
| Tuberous sclerosis | Disease | ||||||||
| Li-Fraumeni syndrome | Disease | ||||||||
| Cowden syndrome | Disease | ||||||||
| Constitutional mismatch repair deficiency syndrome | Disease | ||||||||
| Familial adenomatous polyposis 1 | Disease | ||||||||
| Naevoid basal cell carcinoma syndrome | Disease | ||||||||
| Rhabdoid tumour predisposition syndrome | Disease | ||||||||
| Carney complex | Disease | ||||||||
| DICER1 syndrome | Disease | ||||||||
| Familial paraganglioma syndromes | Disease | ||||||||
| Melanoma-astrocytoma syndrome | Disease | ||||||||
| Familial retinoblastoma | Disease | ||||||||
| BAP1 tumour predisposition syndrome | Disease | ||||||||
| Fanconi anaemia | Disease | ||||||||
| ELP1-medulloblastoma syndrome | Disease |
WHO Breast tumours (5th ed.) Content
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
|---|---|---|---|---|---|---|---|---|---|
| Columnar cell lesions, including flat epithelial atypia | Disease | ||||||||
| Atypical ductal hyperplasia | Disease | ||||||||
| Sclerosing adenosis | Disease | ||||||||
| Apocrine adenosis and adenoma | Disease | ||||||||
| Microglandular adenosis | Disease | ||||||||
| Radial scar / complex sclerosing lesion | Disease | ||||||||
| Tubular adenoma | Disease | ||||||||
| Lactating adenoma | Disease | ||||||||
| Ductal adenoma | Disease | ||||||||
| Pleomorphic adenoma | Disease | ||||||||
| Adenomyoepithelioma | Disease | ||||||||
| Malignant adenomyoepithelioma | Disease | ||||||||
| Intraductal papilloma | Disease | ||||||||
| Papillary ductal carcinoma in situ | Disease | ||||||||
| Encapsulated papillary carcinoma | Disease | ||||||||
| Solid papillary carcinoma (in situ and invasive) | Disease | ||||||||
| Invasive papillary carcinoma | Disease | ||||||||
| Atypical lobular hyperplasia | Disease | ||||||||
| Lobular carcinoma in situ | Disease | ||||||||
| Ductal carcinoma in situ | Disease | ||||||||
| Invasive breast carcinoma: General overview | Disease | ||||||||
| Invasive breast carcinoma of no special type | Disease | ||||||||
| Microinvasive carcinoma | Disease | ||||||||
| Invasive lobular carcinoma | Disease | ||||||||
| Tubular carcinoma | Disease | ||||||||
| Cribriform carcinoma | Disease | ||||||||
| Mucinous carcinoma | Disease | ||||||||
| Mucinous cystadenocarcinoma | Disease | ||||||||
| Invasive micropapillary carcinoma | Disease | ||||||||
| Carcinoma with apocrine differentiation | Disease | ||||||||
| Metaplastic carcinoma | Disease | ||||||||
| Acinic cell carcinoma | Disease | ||||||||
| Adenoid cystic carcinoma | Disease | ||||||||
| Secretory carcinoma | Disease | ||||||||
| Mucoepidermoid carcinoma | Disease | ||||||||
| Polymorphous adenocarcinoma | Disease | ||||||||
| Tall cell carcinoma with reversed polarity | Disease | ||||||||
| Neuroendocrine tumour | Disease | ||||||||
| Neuroendocrine carcinoma | Disease | ||||||||
| Hamartoma | Disease | ||||||||
| Fibroadenoma | Disease | ||||||||
| Phyllodes tumour | Disease | ||||||||
| Syringomatous tumour | Disease | ||||||||
| Nipple adenoma | Disease | ||||||||
| Paget disease of the breast | Disease | ||||||||
| Haemangioma | Disease | ||||||||
| Angiomatosis | Disease | ||||||||
| Atypical vascular lesions | Disease | ||||||||
| Postradiation angiosarcoma of the breast | Disease | ||||||||
| Primary angiosarcoma of the breast | Disease | ||||||||
| Nodular fasciitis | Disease | ||||||||
| Myofibroblastoma | Disease | ||||||||
| Desmoid fibromatosis | Disease | ||||||||
| Inflammatory myofibroblastic tumour | Disease | ||||||||
| Schwannoma | Disease | ||||||||
| Neurofibroma | Disease | ||||||||
| Granular cell tumour | Disease | ||||||||
| Leiomyoma | Disease | ||||||||
| Leiomyosarcoma | Disease | ||||||||
| Lipoma | Disease | ||||||||
| Angiolipoma | Disease | ||||||||
| Liposarcoma | Disease | ||||||||
| Pseudoangiomatous stromal hyperplasia | Disease | ||||||||
| Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) | Disease | ||||||||
| Follicular lymphoma | Disease | ||||||||
| Diffuse large B-cell lymphoma | Disease | ||||||||
| Burkitt lymphoma | Disease | ||||||||
| Breast implant-associated anaplastic large cell lymphoma | Disease | ||||||||
| Gynaecomastia | Disease | ||||||||
| Carcinoma in situ | Disease | ||||||||
| Invasive carcinoma | Disease | ||||||||
| Metastases to the breast | Disease | ||||||||
| BRCA1/2-associated hereditary breast and ovarian cancer syndrome | Disease | ||||||||
| Cowden syndrome | Disease | ||||||||
| Ataxia-telangiectasia | Disease | ||||||||
| Li-Fraumeni syndrome, TP53-associated | Disease | ||||||||
| Li-Fraumeni syndrome, CHEK2-associated | Disease | ||||||||
| CDH1-associated breast cancer | Disease | ||||||||
| PALB2-associated cancers | Disease | ||||||||
| Peutz-Jeghers syndrome | Disease | ||||||||
| Neurofibromatosis type 1 | Disease |